Application 017577
- Type
- NDA
- Sponsor
- JANSSEN PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DITROPAN | OXYBUTYNIN CHLORIDE | TABLET;ORAL | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N017577-001 | DITROPAN | OXYBUTYNIN CHLORIDE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N017577-001 | DITROPAN | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | N017577-001 | DITROPAN | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N017577-001 | DITROPAN | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N017577-001 | DITROPAN | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD, Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | REMEDYREPACK INC. | 1a08a16a-f16d-4ef1-95bb-6943bcae0737 | 2026-07-28 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | TruPharma LLC | 7c497c6c-2448-2c80-e053-2991aa0ab8c7 | 2026-07-27 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | RISING PHARMA HOLDINGS, INC. | 9578b6b8-5b9d-4263-9142-39b2c7216b85 | 2026-07-21 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | ATLANTIC BIOLOGICALS CORP. | fe4ed76b-0009-455f-be30-47e80fc1afdf | 2026-07-09 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Coupler LLC | 55f618d1-4463-3200-e063-6394a90a89a8 | 2026-07-06 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Strides Pharma Science Limited | 9ede5def-d185-4e40-9c10-8663ac654caf | 2026-07-01 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | American Health Packaging | 0c71bdfb-01db-49ac-a8e9-0037df0d24af | 2026-06-24 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Strides Pharma Science Limited | ac10c7b7-d0cb-4068-93e2-c0e51f15866e | 2026-06-01 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 73d715dc-868d-4194-b668-4c39ababa698 | 2026-05-20 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | a5965c8b-179d-4665-8a3b-324b693607ee | 2026-05-19 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | 7db4ab81-b379-4a6d-b469-95eb9e184b56 | 2026-05-14 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | American Health Packaging | 4574b227-9726-4798-bac2-83bfb9616f09 | 2026-04-16 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | b9d0e5c8-3a71-40a0-a7d3-44bc043392fa | 2026-02-17 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | a1f8be75-2eb9-4eef-8fb4-144ef2bf7ae1 | 2026-02-16 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 9a551ec5-7e80-47c9-a7b9-f458c1478174 | 2026-02-16 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Chartwell Governmental & Specialty RX, LLC. | 46e78c72-a5a3-472f-9125-b120fa4eee31 | 2026-01-30 | Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Advagen Pharma Limited | 7bd31561-4c76-4c6b-819b-492549886673 | 2026-01-14 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 3688227b-7655-40ca-b34b-073a39fd60f4 | 2026-01-14 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Northwind Health Company, LLC | f330b7a0-bbe0-0f00-e053-2a95a90a37b8 | 2026-01-01 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Northwind Health Company, LLC | 13a79659-a181-6a61-e063-6294a90ae034 | 2025-12-26 | Warnings, Adverse reactions | OXYBUTYNIN CHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 646 | SUPPL | 2012-03-26 |
| 11034 | SUPPL | 2012-03-23 |
| 13858 | SUPPL | 2011-12-20 |
| 11033 | SUPPL | 2011-12-20 |
| 13857 | SUPPL | 2011-08-10 |
| 11032 | SUPPL | 2011-08-08 |
| 40752 | SUPPL | 2009-09-14 |
| 20080 | SUPPL | 2009-09-14 |
| 11031 | SUPPL | 2009-07-23 |
| 645 | SUPPL | 2009-07-16 |
| 11030 | SUPPL | 2008-02-14 |
| 13856 | SUPPL | 2008-02-13 |
| 13855 | SUPPL | 2003-05-29 |
| 33307 | SUPPL | 2003-04-16 |
| 11029 | SUPPL | 2003-04-16 |